All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know ALL.

The ALL Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

The ALL Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the ALL Hub cannot guarantee the accuracy of translated content. The ALL Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact

What is the cellular origin of ALL?

Jun 30, 2022
Learning objective: After reading this article, learners will be able to cite a new clinical development in ALL

During the EHA 2022 Congress, we spoke with Jan Cools, VIB-KU Leuven Center for Cancer Biology, Leuven, BE. We asked, What is the cellular origin of acute lymphoblastic leukemia (ALL)?

What is the cellular origin of ALL?

Cools begins by discussing his current research into the genetic components of ALL development in adults. He outlines the accumulation of mutations in patients, including heterogeneity amongst patients and developments of leukemic cell mutations post-diagnosis. Cools goes on to discuss research into the cell-of-origin and how single-cell sequencing can provide further clarity. Finally, Cools highlights some insights on the genetic profile of T-cell ALL, particularly the order in which mutations occur in disease development.